Skip to main content
. 2017 Mar 24;20(1):54–64. doi: 10.4048/jbc.2017.20.1.54

Figure 1. Overall survival curves according to the expression of B-cell CLL/lymphoma 2 (BCL2) in each subtype regarding National Comprehensive Cancer Network classification. Survival curves in HR(+)/HER2(−) (A), HR(+)/HER2(+) (B), HR(−)/HER2(+) (C), and HR(−)/HER2(−) (D) subtypes.

Figure 1

HR=hormonal receptor; HER2=human epidermal growth factor receptor 2.